Ivuxolimab, previously known as PF-04518600, represents a new clinical approach as a targeted PD-1 antagonist of the IgG1 isotype. Research suggest that this antibody holds significant potential for treating a wide range of inflammatory problems and, potentially, certain cancers . Its unique mechanism of action, involving precisely blocking PD-1… Read More

Wet age-related macular degeneration AMD , a leading cause of vision loss , has continually created significant challenges for eye doctors . Now, this novel treatment is emerging as a potential therapeutic option . This new therapy blocks vascular endothelial growth VEGF , a key molecule driving abnormal capillary growth in the eye. Early resear… Read More